Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
2076
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.01M | ﹤0.01% |
114,587
+15,418
| +16% | +$602K |
|
2077
Evertec
EVTC
$1.97B
| $4M | ﹤0.01% |
91,749
+27,064
| +42% | +$1.14M |
|
2078
KB Financial Group
KB
$39.5B
| $4M | ﹤0.01% |
81,187
+45,588
| +128% | +$2.28M |
|
|
CLVS
2079
DELISTED
Clovis Oncology, Inc.
CLVS
| $4M | ﹤0.01% |
689,759
+501
| +0.1% | +$2.94K |
|
2080
Lloyds Banking Group
LYG
$85.2B
| $4M | ﹤0.01% |
1,566,839
+34,717
| +2% | +$89.1K |
|
2081
Dr. Reddy's Laboratories
RDY
$9.8B
| $3.99M | ﹤0.01% |
271,480
-192,160
| -41% | -$2.69M |
|
2082
Kirby Corp
KEX
$7.01B
| $3.99M | ﹤0.01% |
65,816
+6,630
| +11% | +$427K |
|
2083
Curis
CRIS
$9.71M
| $3.98M | ﹤0.01% |
1,234
+233
| +23% | +$1.05M |
|
2084
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.31B
| $3.98M | ﹤0.01% |
137,130
-83,570
| -38% | -$2.33M |
|
|
BDN
2085
Brandywine Realty Trust
BDN
$509M
| $3.97M | ﹤0.01% |
289,830
+72,244
| +33% | +$996K |
|
2086
CALL
The Honest Company
HNST
$412M
| $3.97M | ﹤0.01% |
+245,100
| New | +$4.1M |
|
|
LTC
2087
LTC Properties
LTC
$2.13B
| $3.96M | ﹤0.01% |
103,285
+40,415
| +64% | +$1.65M |
|
2088
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.9B
| $3.96M | ﹤0.01% |
113,492
-57,099
| -33% | -$1.99M |
|
2089
CALL
TC Energy
TRP
$70.1B
| $3.96M | ﹤0.01% |
80,000
| – | – |
|
2090
Associated Banc-Corp
ASB
$5.8B
| $3.96M | ﹤0.01% |
193,363
-11,042
| -5% | -$244K |
|
2091
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.4B
| $3.96M | ﹤0.01% |
35,676
-10,370
| -23% | -$1.14M |
|
2092
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $3.96M | ﹤0.01% |
+72,900
| New | +$3.88M |
|
|
EFIX
2093
DELISTED
First Trust TCW Emerging Markets Debt ETF
EFIX
| $3.96M | ﹤0.01% |
200,000
| – | – |
|
|
ADAM
2094
Adamas Trust
ADAM
$777M
| $3.95M | ﹤0.01% |
221,166
+179,151
| +426% | +$3.26M |
|
2095
UFP Industries
UFPI
$4.95B
| $3.95M | ﹤0.01% |
53,135
+14,473
| +37% | +$1.14M |
|
2096
Xencor
XNCR
$1.45B
| $3.94M | ﹤0.01% |
114,315
+24,757
| +28% | +$982K |
|
2097
Sociedad Química y Minera de Chile
SQM
$19.3B
| $3.94M | ﹤0.01% |
83,237
+8,338
| +11% | +$411K |
|
|
KRTX
2098
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.93M | ﹤0.01% |
34,480
-3,557
| -9% | -$416K |
|
|
OSH
2099
DELISTED
Oak Street Health, Inc.
OSH
| $3.93M | ﹤0.01% |
67,074
+51,294
| +325% | +$3.05M |
|
|
MCFE
2100
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $3.92M | ﹤0.01% |
139,923
-8,412
| -6% | -$216K |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.